Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies.Business Overview Amwill Health Care Ltd is a derma-cosmetic company specializing in contract manufacturing, distribution, and third-party product development. It focuses on dermatological and aesthetic solutions, operating on an asset-light model...
**AMWILL HEALTH CARE LIMITED** Amwill Health Care has announced its 8th Annual General Meeting (AGM) will be held on August 14, 2025, via video conferencing/other audio-visual means. The company has provided e-voting facilities, which will be open from August 11 to August 13, 2025. The cut-off date to determine eligible...
Amwill Health Care Limited has announced that its Registrar and Transfer Agent, Bigshare Services Pvt. Ltd., has confirmed compliance with share dematerialisation and rematerialisation requirements for the quarter. No requests for dematerialisation or rematerialisation of shares were received during the period. This indicates stable shareholding patterns without changes in the...
Amwill Healthcare Limited has announced a strategic expansion into high-potential markets including Maharashtra, Tamil Nadu, North East India, Chhattisgarh, and Madhya Pradesh, complementing its strong presence in Karnataka, Andhra Pradesh, and Telangana. The company has strengthened its sales team to support these new operations, which have now commenced successfully. Alongside...
Amwill Health Care Limited has confirmed no deviation or variation in the utilization of IPO proceeds compared to the objectives outlined in its prospectus. The Audit Committee reviewed and approved the statement on fund utilization for the half-year ending 31st March 2025. This indicates disciplined financial management post-IPO, reassuring shareholders...
Amwill Health Care Limited has announced that it is not required to comply with the Annual Secretarial Compliance Report as per applicable listing regulations, being listed on the SME Platform of BSE. This clarifies the company's current regulatory obligations, reducing potential compliance workload and related expenses for shareholders.
